From: Differential discounting in the economic evaluation of healthcare programs
Author | Data base | Results |
---|---|---|
Studies included in Ryen and Svensson [86] | ||
 Byrne et al. 2005 [88] | GP (130 ≤ n ≥ 160), USA | 0.16–0.27 |
 King et al. 2005 [89] | Hospital patients (n = 391), USA | 0.30–0.87 |
 Bobinac et al. 2010 [90] | GP (n = 1091), The Netherlands | 0.05–0.21a |
 Shiroiwa et al. 2010 [91] | GP (504 ≤ n ≥ 1114), Japan, South Korea, Taiwan, Australia, United Kingdom, USA | J: 0.37 SK: 0.53 T: 0.69 AUS: 0.73 UK: 0.77 USA: 1.02 |
 Haninger et al. 2011 [92] | GP (n = 2858), USA | 0.02–0.15 |
 Zhao et al. 2011 [93] | GP (n = 364), China | 0.00–0.02a |
 Bobinac et al. 2013 [94] | GP (n = 1004), The Netherlands | 0.17–0.23a |
 Thavorncharoensap et al. 2013 [95] | GP (n = 1191), Thailand | 0.31 |
 Shiroiwa et al. 2013 [96] | GP (n = 2283), Japan | 0.03–0.16 |
Studies not included in Ryen and Svenson [86] | ||
 Ahlert et al. 2016 [87] | GP (507 ≤ n ≥ 1501), Germany | 0.12–0.40 |